A critical, science-based analysis of Abigail Shrier's book Irreversible Damage.
Paid speeches at lavish events touting drugs and medical devices risk charges of anti-kickback law violations, warns a recent government Special Fraud Alert. Will companies and doctors take heed this time?
Libella Gene Therapeutics, LLC made the news last week for announcing a "pay-to-play" trial of its telomerase-based anti-aging gene therapy. What was shocking about the announcement was not that it was a "pay-to-play" trial, given that such trials have become all too common, but rather the price of enrollment: $1 million. Worse, the trial is being conducted in Colombia; the therapy doesn't...
Nurse practitioner aggressively advertises a plethora of aesthetic treatments, some of which are dubious. It's legal, but is it ethical?
A CME article in American Family Physician misrepresents the evidence, claiming acupuncture has been proven safe and effective. An accompanying editorial gives despicable advice on how to manipulate patients to accept this theatrical placebo.
There's no reliable evidence that an infusion of blood plasma from a young donor will benefit an older person, and there are risks, but Ambrosia Health is selling "young blood" infusions for thousands of dollars anyway. The FDA has taken notice.
Last week, Annabelle Potts, a girl with the deadly brain cancer DIPG, passed away. She had made the news in Australia and worldwide because she had been treated at Clínica 0-19 in Monterrey, Mexico, where Drs. Alberto Garcia and Alberto Siller treat DIPG patients with a secret unproven mix of intra-arterial chemotherapy injected directly into the arteries feeding the brainstem, all while...
The stem cell hard sell: The Medical Board of California is forming a task force to determine how to regulate physicians offering stem cell therapies.
For-profit stem cell clinics selling unproven and downright quacky stem cell therapies have proliferated over the last several years, with federal and state law seemingly powerless to stop them. Recently, the FDA and FTC have shown signs of acting to crack down on them. Now, the Medical Board of California is forming a task force to determine how to regulate physicians offering...
A Chinese scientist announces first gene-edited babies, setting off a discussion of the science and ethics of using CRISPR on humans.